Sertraline
- TRADE NAME: Atruline; Zoloft (Pfizer)
- INDICATIONS: Depression, panic disorders, obsessive compulsive disorders
- CLASS: Antidepressant, Selective serotonin reuptake inhibitor (SSRI)
- HALF-LIFE: 24–26 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Amphetamines, Astemizole, Clarithromycin, Clozapine, Dextroamphetamine, Diethylpropion, Droperidol, Erythromycin, Isocarboxazid, Linezolid, MAO inhibitors, Mazindol, Methamphetamine, Metoclopramide, Phendimetrazine, Phenelzine, Phentermine, Phenylpropanolamine, Pimozide, Pseudoephedrine, Selegiline, Sibutramine, St John's Wort, Sumatriptan, Sympathomimetics, Tranylcypromine, Trazodone, Troleandomycin, Zolmitriptan
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN
HAIR
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
GENITOURINARY
OTIC
OCULAR
OTHER
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life Threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric